NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nucliq Biologics

Nucliq Biologics

Private
St. John's, Newfoundland and LabradorHealthcare & Life Scienceshttps://nucliqbio.ca/

Last Round

Seed

Apr 24, 2025

Total Funding Raised

$760,000

Company Overview

Nucliq Biologics is a biotechnology company that develops microbiome-based personalized therapeutics, diagnostics, and at-home testing kits using microbiome science and artificial intelligence.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Medical Devices, D2C Brands

Business Model

B2C

Customer Profile

Hardware Sales, Data as a Service, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

gut microbiome analysismicrobiome testat-home test kitAI drug discoverymicrobiome therapeuticsdrug discovery platformgut healthpersonalized nutritionmulti-omics analysisD2C healthwomen's healthMedical Device Establishment LicenseMDELhealth techbiotech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nucliq Biologics Comparables

Compare Nucliq Biologics with similar companies based on industry and business-model similarity.

Nucliq Biologics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Jona
82%
Biohm Technologies
81%
Tiny Health
80%

Nucliq Biologics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedApr 24, 2025
GrantJan 17, 2024
GrantJun 16, 2020

Key People

Founding team and executive leadership

Purvikalyan Pallegar

Co-founder CTO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 5, 2025

    Monthly visitors increased 67% MoM.

  • Jun 1, 2025

    Monthly visitors increased 65% MoM.

Nucliq Biologics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nucliq Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nucliq Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSt. John's, Newfoundland and Labrador
Employee Range14
Year Founded2019
Last FundingApr 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.